Bone morphogenetic protein receptor and integrin complex (BMPR-Integrin)

The physiologic Bone Morphogenetic Protein (BMP) receptors and integrins on osteoprogenitor and mesenchymal stem cells (MSCs) function as a coordinated signaling unit essential for skeletal development and bone repair. BMP receptors, such as BMPR1A and BMPR2, are transmembrane serine/threonine kinases that initiate the Smad signaling cascade, while integrins (e.g., alpha-V beta-3 or alpha-5 beta-1) mediate cell attachment to the extracellular matrix and provide necessary co-stimulatory signals. This receptor crosstalk is critical for the recruitment of progenitor cells to injury sites and their subsequent differentiation into bone-forming osteoblasts (PMID: 27159345, UniProt P36894). Clinically, this system is the primary target for recombinant human BMPs, such as rhBMP-2 (Dibotermin alfa), used in spinal fusion and the treatment of non-union fractures to accelerate bone healing (FDA, Infuse Bone Graft). However, therapeutic intervention is complicated by the need for precise localization, as off-target activation can lead to significant safety issues like ectopic ossification and inflammatory complications (PMID: 24033715). Understanding the interplay between these receptors is a major focus in regenerative medicine for developing advanced biomaterials that mimic the natural bone niche.

Other names

BMP receptor-Integrin crosstalk complexBMPR-Integrin signaling axisOsteoprogenitor BMP-Integrin receptors

Activation of Smad-dependent (canonical) and MAPK/ERK (non-canonical) signaling pathways through synergistic ligand binding and physical receptor coupling, promoting osteogenic gene expression.